Johanne Kaplan

CIK: 0001967717

Transaction Breakdown

Open Market Buys (P)2 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PMN

ProMIS Neurosciences Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

PMN
ProMIS Neurosciences Inc.
Aug 5, 2026
Purchase(P)
Direct
2.3K shares at avg. $13.30$30K
PMN
ProMIS Neurosciences Inc.
May 20, 2026
Award(A)
Option (right to buy)
Direct
50K shares-
PMN
ProMIS Neurosciences Inc.
Feb 19, 2026
Purchase(P)
Direct
1.6K shares at avg. $15.35$25K
PMN
ProMIS Neurosciences Inc.
Feb 3, 2026
Award(A)
Direct
2.1K shares at avg. $12.13$25K
PMN
ProMIS Neurosciences Inc.
Sep 22, 2025
Award(A)
Option (right to buy)
Direct
165K shares-
PMN
ProMIS Neurosciences Inc.
Nov 18, 2024
Award(A)
Option (right to buy)
Direct
175K shares-

		Type	Shares	Price		Ownership
Aug 5, 2026	PMN ProMIS Neurosciences Inc.	Purchase(P)	2,280	$13.30	$30,324	Direct
May 20, 2026	PMN ProMIS Neurosciences Inc.	Award(A) Option (right to buy)	50,000	-	-	Direct
Feb 19, 2026	PMN ProMIS Neurosciences Inc.	Purchase(P)	1,629	$15.35	$25,005	Direct
Feb 3, 2026	PMN ProMIS Neurosciences Inc.	Award(A)	2,060	$12.13	$24,988	Direct
Sep 22, 2025	PMN ProMIS Neurosciences Inc.	Award(A) Option (right to buy)	165,000	-	-	Direct
Nov 18, 2024	PMN ProMIS Neurosciences Inc.	Award(A) Option (right to buy)	175,000	-	-	Direct

1-6 of 6 transactions

About Kaplan Johanne

Kaplan Johanne (SEC CIK 0001967717) files insider reports with the SEC as Chief Development Officer of ProMIS Neurosciences Inc. (PMN).

Signal8 holds 6 ownership filings by Kaplan Johanne, all Form 4s, filed between Nov 20, 2024 and Aug 7, 2026. Those filings report 6 transactions, from Nov 18, 2024 to Aug 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kaplan Johanne's filings is in TORONTO.

Recent filings by Kaplan Johanne

Aug 5, 2026: Open-market purchase of PMN shares (Form 4, code P).
May 20, 2026: Grant or award of PMN derivative securities (Form 4, code A).
Feb 19, 2026: Open-market purchase of PMN shares (Form 4, code P).
Feb 3, 2026: Grant or award of PMN shares (Form 4, code A).
Sep 22, 2025: Grant or award of PMN derivative securities (Form 4, code A).

Other insiders filing for ProMIS Neurosciences Inc. (PMN)

Williams Eugene, Director
Cashman Neil, Chief Scientific Officer
Rubino Ivana, Chief Commercial Officer
WYMAN WILLIAM W, Director
Warma Neil K, Chief Executive Officer
Shafmaster Madge K., Director

How to read Form 4 transaction codes